Keiretsu Forum Toronto News Today : Breaking News, Live Updates & Top Stories | Vimarsana

An Ottawa-based startup working on treatments that use the body’s immune system to target cancer, COVID-19 and other diseases has landed millions of dollars in financing to ratchet up its research efforts.
Orion Biotechnology’s new series-A round worth US$11.5 million is being led by Keiretsu Forum, a global syndicate of angel investors headquartered in San Francisco. 
The new funding will help the firm expand its clinical trials of drug candidates produced by its proprietary platform that targets G-protein coupled receptors, or GPCRs, which play a key role in diseases such as cancer, HIV and acute respiratory distress syndrome (ARDS) associated with the virus that causes COVID-19. ....

United Kingdom , San Francisco , United States , John Jussup , Brian Mcgowan , Oliver Hartley , Keiretsu Forum Toronto , National Research Council Of Canada , Halogen Software , Keiretsu Forum , Winnipeg National Microbiology Laboratory , University Of Geneva , Mark Groper , Nobel Prize , Gregory Winter , Glaxo Wellcome , National Research Council , National Microbiology Laboratory , ஒன்றுபட்டது கிஂக்டம் , சான் பிரான்சிஸ்கோ , ஒன்றுபட்டது மாநிலங்களில் , ஈயந் மகோவெந் , ஆலிவர் ஹார்ட்லி , தேசிய ஆராய்ச்சி சபை ஆஃப் கனடா , ஆலசன் மென்பொருள் , வின்னிபெக் தேசிய நுண்ணுயிரியல் ஆய்வகம் ,